Six AI-picked stocks are up 50%+; the top IT name has gained 33%

Investing.com says its Mid-Cap Movers strategy has returned 104.6% cumulatively since its November 2023 live launch, 49.3 percentage points ahead of the S&P Midcap 400. Insight Enterprises gained 33.7% since its July 1 pick; its Q2 FY2026 EPS of $3.86 beat the $2.93 consensus by 31.7%, and the stock rose 6.4% on the report day. Amneal Pharmaceuticals’ Q2 EPS of $0.30 beat the $0.23 consensus by 30.4%, while its shares are up 52.3% since the June 1 pick; the article notes past performance does not guarantee future results.

Analysis

The actionable signal is not the advertised model record; it is whether Insight Enterprises can convert AI/cloud demand into durable gross-profit dollars rather than simply moving more hardware. A mix shift could improve earnings quality over 6–18 months, but infrastructure sales can also raise low-margin revenue and working-capital needs. Suppliers such as Dell and HPE may capture equipment demand regardless of which reseller wins, so NSIT’s differentiation depends on services attachment and customer retention—not AI exposure alone.

The promotional performance figures are weak evidence of repeatable alpha without a point-in-time constituent history, delisted-stock treatment, drawdowns, turnover, and returns net of costs. Recent winners may also create crowding and make the strategy’s equal-weight headline return difficult to replicate.

Near term, NSIT’s proximity to its high and the prior rally argue against chasing ahead of the October 29 report. The key 1–3 month test is whether cloud/services gross profit and EBITDA growth persist and guidance supports the mix-shift thesis. Over 6–18 months, a slowdown in enterprise IT budgets or AI infrastructure spending could expose the lower-quality side of the revenue mix. A reported revenue beat without improving gross-profit dollars, weaker cash conversion, or a guidance cut would falsify the bullish case. The evidence supplied does not support a fresh position in the other promoted names.

Key Decisions for Investors

• NSIT: Do not chase into the October 29 event. Put it on an earnings-trigger watch; consider a staged long only if reported services/cloud gross-profit growth and cash conversion confirm the mix-shift thesis and guidance is maintained. Invalidate on weaker gross-profit dollars, deteriorating cash conversion, or a guidance cut.
• For a more market-neutral expression, evaluate a conditional long NSIT / short CDW pair only after comparing valuation, services mix, and earnings revisions; the article supplies none of those relative metrics, so this is a research alert, not a current recommendation.
• Do not allocate on the advertised AI-strategy track record until the provider supplies auditable monthly holdings, benchmark methodology, drawdowns, turnover, and net-of-cost returns. Treat the highlighted gains as selection evidence, not proof of a repeatable edge.
• No trade in AMRX, CCSI, CVI, DINO, DK, or EFOR from this article alone: the retrospective returns lack current valuation, forward estimates, and company-specific catalysts needed to assess remaining upside or downside.